Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Nasdaq Real Time Price USD

biote Corp. (BTMD)

Compare
3.3600
-0.1000
(-2.89%)
At close: 4:00:01 PM EDT
3.3600
0.00
(0.00%)
After hours: 4:05:10 PM EDT
Loading Chart for BTMD
  • Previous Close 3.4600
  • Open 3.4100
  • Bid 2.4700 x 200
  • Ask 4.1800 x 200
  • Day's Range 3.2200 - 3.4100
  • 52 Week Range 3.0400 - 8.4400
  • Volume 137,170
  • Avg. Volume 199,703
  • Market Cap (intraday) 178.493M
  • Beta (5Y Monthly) 1.17
  • PE Ratio (TTM) 37.33
  • EPS (TTM) 0.0900
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.47

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

www.biote.com

217

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BTMD

View More

Performance Overview: BTMD

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BTMD
45.63%
S&P 500 (^GSPC)
8.25%

1-Year Return

BTMD
43.05%
S&P 500 (^GSPC)
3.55%

3-Year Return

BTMD
65.92%
S&P 500 (^GSPC)
18.71%

5-Year Return

BTMD
66.57%
S&P 500 (^GSPC)
116.85%

Compare To: BTMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BTMD

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    108.94M

  • Enterprise Value

    180.46M

  • Trailing P/E

    38.44

  • Forward P/E

    6.53

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.92

  • Enterprise Value/EBITDA

    11.57

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.60%

  • Return on Assets (ttm)

    16.96%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    197.19M

  • Net Income Avi to Common (ttm)

    3.16M

  • Diluted EPS (ttm)

    0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    39.34M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    56.49M

Research Analysis: BTMD

View More

Company Insights: BTMD

Research Reports: BTMD

View More

People Also Watch